191 related articles for article (PubMed ID: 31865743)
1. Opioid utility function: methods and implications.
van Dam CJ; Algera MH; Olofsen E; Aarts L; Smith T; van Velzen M; Sarton E; Niesters M; Dahan A
Ann Palliat Med; 2020 Mar; 9(2):528-536. PubMed ID: 31865743
[TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
3. A Pragmatic Utility Function to Describe the Risk-Benefit Composite of Opioid and Nonopioid Analgesic Medication.
Olesen AE; Broens S; Olesen SS; Niesters M; van Velzen M; Drewes AM; Dahan A; Olofsen E
J Pharmacol Exp Ther; 2019 Nov; 371(2):416-421. PubMed ID: 30442653
[TBL] [Abstract][Full Text] [Related]
4. Benefit versus Severe Side Effects of Opioid Analgesia: Novel Utility Functions of Probability of Analgesia and Respiratory Depression.
Roozekrans M; van der Schrier R; Aarts L; Sarton E; van Velzen M; Niesters M; Dahan A; Olofsen E
Anesthesiology; 2018 May; 128(5):932-942. PubMed ID: 29498950
[TBL] [Abstract][Full Text] [Related]
5. Opioid MOP receptor agonists in late-stage development for the treatment of postoperative pain.
Qiu Q; Chew JC; Irwin MG
Expert Opin Pharmacother; 2022 Nov; 23(16):1831-1843. PubMed ID: 36302462
[TBL] [Abstract][Full Text] [Related]
6. Designing safer analgesics: a focus on μ-opioid receptor pathways.
Pergolizzi JV; LeQuang JA; Taylor R; Ossipov MH; Colucci D; Raffa RB
Expert Opin Drug Discov; 2018 Oct; 13(10):965-972. PubMed ID: 30175624
[TBL] [Abstract][Full Text] [Related]
7. Partial versus full agonists for opioid-mediated analgesia--focus on fentanyl and buprenorphine.
Zuurmond WW; Meert TF; Noorduin H
Acta Anaesthesiol Belg; 2002; 53(3):193-201. PubMed ID: 12461829
[TBL] [Abstract][Full Text] [Related]
8. Implications of opioid analgesia for medically complicated patients.
Smith H; Bruckenthal P
Drugs Aging; 2010 May; 27(5):417-33. PubMed ID: 20450239
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness and tolerance of tramadol in cancer pain. A comparative study with respect to buprenorphine].
Bono AV; Cuffari S
Drugs; 1997; 53 Suppl 2():40-9. PubMed ID: 9190324
[TBL] [Abstract][Full Text] [Related]
10. Buprenorphine buccal film for chronic pain management.
Hale M; Gimbel J; Rauck R
Pain Manag; 2020 Jul; 10(4):213-223. PubMed ID: 32394800
[TBL] [Abstract][Full Text] [Related]
11. Fentanyl utility function: a risk-benefit composite of pain relief and breathing responses.
Boom M; Olofsen E; Neukirchen M; Fussen R; Hay J; Groeneveld GJ; Aarts L; Sarton E; Dahan A
Anesthesiology; 2013 Sep; 119(3):663-74. PubMed ID: 23756452
[TBL] [Abstract][Full Text] [Related]
12. APOLLO-2: A Randomized, Placebo and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein-Biased Ligand at the μ-Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty.
Singla NK; Skobieranda F; Soergel DG; Salamea M; Burt DA; Demitrack MA; Viscusi ER
Pain Pract; 2019 Sep; 19(7):715-731. PubMed ID: 31162798
[TBL] [Abstract][Full Text] [Related]
13. Does nalbuphine have a niche in managing pain?
Davis MP; Fernandez C; Regel S; McPherson ML
J Opioid Manag; 2018; 14(2):143-151. PubMed ID: 29733100
[TBL] [Abstract][Full Text] [Related]
14. Opioid analgesics: comparative features and prescribing guidelines.
Cherny NI
Drugs; 1996 May; 51(5):713-37. PubMed ID: 8861543
[TBL] [Abstract][Full Text] [Related]
15. Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist.
Linz K; Christoph T; Tzschentke TM; Koch T; Schiene K; Gautrois M; Schröder W; Kögel BY; Beier H; Englberger W; Schunk S; De Vry J; Jahnel U; Frosch S
J Pharmacol Exp Ther; 2014 Jun; 349(3):535-48. PubMed ID: 24713140
[TBL] [Abstract][Full Text] [Related]
16. The Opioid Wars-CON: The Risks of Opioids for Pain Management Outweigh the Benefits.
Anderson TA
Clin J Pain; 2019 Jun; 35(6):463-467. PubMed ID: 30985394
[TBL] [Abstract][Full Text] [Related]
17. Responsible prescribing of opioids for the management of chronic pain.
Nicholson B
Drugs; 2003; 63(1):17-32. PubMed ID: 12487620
[TBL] [Abstract][Full Text] [Related]
18. Analgesia: Screening for cleaner pain relief.
Kingwell K
Nat Rev Drug Discov; 2016 Sep; 15(10):677. PubMed ID: 27681793
[No Abstract] [Full Text] [Related]
19. Low dose ketamine use in the emergency department, a new direction in pain management.
Pourmand A; Mazer-Amirshahi M; Royall C; Alhawas R; Shesser R
Am J Emerg Med; 2017 Jun; 35(6):918-921. PubMed ID: 28285863
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics of opioids and perioperative pain management.
Sadhasivam S; Chidambaran V
Pharmacogenomics; 2012 Nov; 13(15):1719-40. PubMed ID: 23171337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
